Erytech

Closed

Helping patients live longer, better.

Public · Lyon, France · Founded 2004 · $274.6M raised

Headquarters
Lyon
Employees
51–200
Founded
2004
Business Model
B2B
Total Funding
$274.6M
Last Round
$144.0M Private EquityNov 2017
Rounds
4
Type
Public

About

ERYTECH is a clinical-stage biopharmaceutical company that developed innovative red blood cell-based therapeutics to treat severe forms of cancer and orphan diseases. Founded in Lyon, France in 2004, the company focused on encapsulating therapeutic agents inside red blood cells to reduce toxicity and improve efficacy. ERYTECH was listed on the Nasdaq Capital Market and Euronext Paris. The company later merged with PHERECYDES to form PHAXIAM Therapeutics, which subsequently entered judicial restructuring in 2025.

Summary

Erytech is a Biopharmaceutical company based in Lyon, France, founded in 2004. It has raised $274.6M in total across 4 rounds, most recently a $144.0M Private Equity round in Nov 2017.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingDebt FinancingJun 2020

Sign up to see all 6 rounds

IPO through Debt Financing — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Erytech on Indexed.vc
<a href="https://indexed.vc/companies/erytech-pharma-sa"><img src="https://indexed.vc/api/badge/company/erytech-pharma-sa" alt="Erytech on Indexed.vc" width="260" height="76" /></a>